
21.95 Delayed Data As of Dec 01 | ![]() Today’s Change | 15.32 Today|||52-Week Range 22.80 | +36.85% Year-to-Date |
Exelixis (EXEL) Up 8.4% Since Last Earnings Report: Can It Continue? Dec 01 / Zacks.com - Paid Partner Content | Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Nov 27 / Zacks.com - Paid Partner Content |
Previous close | 21.81 |
Today’s open | 21.81 |
Day’s range | 21.64 - 21.98 |
Volume | 121,449 |
Average volume (3 months) | 2,320,451 |
Market cap | $6.8B |
Earnings growth (last year) | -22.74% |
Earnings growth (this year) | +26.53% |
Earnings growth (next 5 years) | +24.18% |
Revenue growth (last year) | +12.27% |
P/E ratio | 75.7 |
Price/Sales | 3.23 |
Price/Book | 2.86 |
Today’s change | Today’s % change | |
---|---|---|
MEDPMedpace Holdings Inc | +4.85 | +1.79% |
---- | ||
CRLCharles River Labora... | +4.63 | +2.35% |
---- |
Next reporting date | February 27, 2024 |
EPS forecast (this quarter) | $0.20 |
Annual revenue (last year) | $1.6B |
Annual profit (last year) | $182.3M |
Net profit margin | 11.31% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Alameda, California |